E. Humblet

发表

CROHN’S DISEASE WHO FAILED BIOLOGIC THERAPIES: A NATIONAL COHORT STUDY

M. Vos, S. Vermeire, E. Louis, 2020 .

Long-term clinical effectiveness of ustekinumab in patients with Crohn's disease who failed biological therapies: a national cohort study.

D. Franchimont, S. Vermeire, E. Louis, 2019, Journal of Crohn's & colitis.

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study

S. Vermeire, E. Louis, M. Ferrante, 2020, Alimentary pharmacology & therapeutics.

Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response

D. Franchimont, S. Vermeire, A. Gils, 2021, GastroHep.

Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab

D. Franchimont, S. Vermeire, M. Ferrante, 2018, Journal of Crohn's & colitis.

Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial

P. Rutgeerts, S. Vermeire, A. Gils, 2011, Gut.

Laryngeal Manifestations of Inflammatory Bowel Disease.

V. Poorten, E. Loos, P. Lemkens, 2019, Journal of voice : official journal of the Voice Foundation.

Su1846 – Outcomes of Pregnancy in IBD Patietns Treated with Vedolizumab, Anti-TNF Or Conventional Therapy

S. Vermeire, E. Louis, M. Ferrante, 2019, Gastroenterology.

Sa1697 - Outcome of Pregnancies in Vedolizumab Treated Female IBD Patients

D. Franchimont, S. Vermeire, M. Ferrante, 2018 .

OP032 Outcome of pregnancies in female IBD patients treated with vedolizumab

D. Franchimont, S. Vermeire, M. Ferrante, 2018 .